Developing effective vaccines against a deadly global pandemic is certainly bullish for a stock.
Indeed, Moderna and Pfizer shareholders have put away as much as 516% and 51% gains, respectively.
And when a lot of investors see this, they fear theyāve missed out.
Well, Michaelās here to assure you that you havenāt; not by a long shot.
And today, heās got a vaccine stock you should put at the top of your āmust-buyā list for the week ahead⦠.
Start the conversation